All posts by: Michael Zand

CRISPR Turbocharges CAR T Cells, Boosts Cancer Immunotherapy – Genetic Engineering & Biotechnology News

MIODx Licenses Key Immunotherapy Technologies from UCSF – Yahoo Finance

MIODx Licenses Key Immunotherapy Technologies from UCSFYahoo FinanceSAN JOSE, Calif., Feb. 23, 2017 /PRNewswire/ — MIODx announced today that it has signed an exclusive license for two key immunotherapy technologies from the University of California, … Continue reading

MIODx Licenses Key Immunotherapy Technologies from UCSF – PR Newswire (press release)

MIODx Licenses Key Immunotherapy Technologies from UCSFPR Newswire (press release)SAN JOSE, Calif., Feb. 23, 2017 /PRNewswire/ — MIODx announced today that it has signed an exclusive license for two key immunotherapy technologies from …UCSF Lic… Continue reading

CRISPR/Cas9: A DNA-Changing Therapy for Duchenne Muscular Dystrophy – Muscular Dystrophy News

Muscular Dystrophy NewsCRISPR/Cas9: A DNA-Changing Therapy for Duchenne Muscular DystrophyMuscular Dystrophy NewsResearchers have identified a way of changing parts of DNA sequencing to be used as a treatment for genetic diseases. The CRISPR/Cas9 thera… Continue reading

Immunotherapy Duo Trumps Single Agent in Metastatic Bladder Cancer – Curetoday.com

Curetoday.comImmunotherapy Duo Trumps Single Agent in Metastatic Bladder CancerCuretoday.comImmunotherapy Duo Trumps Single Agent in Metastatic Bladder Cancer. Patients with metastatic bladder cancer who did not see a benefit on single-agent Opdivo did… Continue reading